Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

NCT01666210 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Inflammation and Pain

Interventions

DRUG: OTX-DP (Dexamethasone punctum plug)
DRUG: Placebo Vehicle Punctum Plug

Sponsor

Ocular Therapeutix, Inc.